In the course of a survey conducted in 59 hospitals performing thoraci
c surgery, 14 hospitals supplied data that could be used for the study
. Out of 1347 anomalies diagnosed 1343 were surgically treated, with a
30-day mortality rate of 0.3% (5 patients). In a retrospective study
over a period of 10 years (1978-1988) we identified 198 anomalies out
of a total of 6350 thoracotomies ; so our percentage grading of pulmon
ary anomalies is supported by the data of the above-mentioned survey a
ccording to which cystic pulmonary malformations such as inhibition ma
lformations, excess malformation and lobar emphysema represent a major
ity with 72.2% (survey 83%). Congenital anomalies of lung formation oc
curred in 23% of the patients of the survey and in 15% of our own pati
ents. Therapy consisted of parenchyma-saving surgery, i.e. enucleation
(n = 87), segmental resection (n = 65) and lobectomy (n = 63) with br
onchoplastic reconstruction; there was no 30-day mortality. Adenomatoi
d-cystic malformation, lymphangiectasis, congenital lobar emphysema an
d stenosis of the tracheobronchial tree are often an indication for im
mediate surgical treatment in neonates. Solitary cysts, bronchiectasis
, sequestration of the lung, an AV-fistula present with symptoms mostl
y between the ages of 20-40 and therefore were surgically treated seco
ndarily.